Indian companies eye new trade channels in US amid erosion of generic prices
Indian drug makers struggling with trade channel consolidation and rapid erosion of generic drugs prices in the US, are exploring platforms such as Amazon, American billionaire Mark Cuban's CostPlus Drug Company and other specialty and…